PRESTIGE_NURSING_(FRANCHI - Accounts


Company registration number 03293367 (England and Wales)
PRESTIGE NURSING (FRANCHISE) LTD
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2022
PRESTIGE NURSING (FRANCHISE) LTD
COMPANY INFORMATION
Directors
Mr S Mistry
Mr D J B Sandoz
Mrs J M Renton
Mrs V Sapojnic
Secretary
Sodexo Corporate Services (No.2) Limited
Company number
03293367
Registered office
1st Floor
Kirkgate
19-31 Church Street
Epsom
Surrey
KT17 4PF
Auditor
KPMG LLP
1 St. Peter's Square
Manchester
M2 3AE
PRESTIGE NURSING (FRANCHISE) LTD
CONTENTS
Page
Directors' report
1 - 2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Statement of financial position
8
Statement of changes in equity
9
Notes to the financial statements
10 - 17
PRESTIGE NURSING (FRANCHISE) LTD
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 AUGUST 2022
- 1 -

The directors present their annual report and financial statements for the year ended 31 August 2022.

Principal activities

The principal activity of the company continued to be franchisor of the Prestige Nursing & Care brand.

 

Results and dividends

The results for the year are set out on page 7. The company's profit after tax for the year was £512,889 (2021: £455,146) and net assets as at 31 August 2022 were £663,222 (2021: £150,333).

No ordinary dividends were paid (2021: £435,000). The directors do not recommend payment of a final dividend.

No preference dividends were paid (2021: £nil). The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr S Mistry
Mr D J B Sandoz
Mrs J M Renton
Mrs V Sapojnic
Supplier payment policy

The company's current policy concerning the payment of trade creditors is to follow the CBI's Prompt Payers Code (copies are available from the CBI, Centre Point, 103 New Oxford Street, London WC1A 1DU).

 

The company's current policy concerning the payment of trade creditors is to:

  • settle the terms of payment with suppliers when agreeing the terms of each transaction;

  • ensure that suppliers are made aware of the terms of payment by inclusion of the relevant terms in contracts; and

  • pay in accordance with the company's contractual and other legal obligations.

 

Trade creditors of the company at the year end were equivalent to 199 day's purchases, based on the average daily amount invoiced by suppliers during the year.

 

Employees

The company does not have any employees.

Political donations

The company made no political donations or incurred any political expenditure during the year.

Energy and carbon report
The company does not qualify as a large company under the Streamlined Energy and Carbon Reporting (SECR) regulations and is not required to report on its emissions, energy consumption or energy efficiency activities in this reporting period.
Auditor
Persuant to section 487 of the Companies Act 2006, the auditor will be deemed to be reappointed and KPMG LLP will therefore continue in office.
Statement of disclosure to auditor

The directors who held office at the date of approval of this directors’ report confirm that, so far as they are each aware, there is no relevant audit information of which the company’s auditor is unaware; and each director has taken all the steps that he/ she ought to have taken as a director to make himself/ herself aware of any relevant audit information and to establish that the company’s auditor is aware of that information.

PRESTIGE NURSING (FRANCHISE) LTD
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
- 2 -
Going concern

The directors continue to adopt the going concern basis in the preparation of the financial statements.

 

The business has remained resilient through the UK wide Covid-19 lockdowns which ended on 18 July 2021 due to the essential nature of the service its franchisees provide and the high proportion of local government and health service clients. We continue to see opportunities for organic growth provided that we can continue to attract, recruit and retain professional carer in an increasingly tight labour market.

 

As inflationary pressures increase, we continue to work with our franchisees and their clients to ensure they receive a fair price for the services that they provide, so that they can continue to invest in their workforce. Agility, good commercial management, and careful cost control continue to be critical to our mutual ongoing success.

 

To inform the basis of preparation of these accounts, the directors have considered cash and profit scenarios for forward trade over the next 12 months.

 

Routine peaks in cash requirements during the trading cycle, can be funded from the significant cash balance the company / its immediate parent company (Prestige Nursing Ltd) has on hand at the end of the 2022 financial year.

 

As at the date of approval of the financial statements, the shareholders of Prestige Nursing Ltd are exploring various strategic options with regard to their shareholding, including the sale of their shares. Although the outcome of the process is currently uncertain, the directors have considered the consequences if a sale was to occur in the forecast period. It is not possible to predict what would happen to the entity if there was a sale, however, the directors have no reason to believe that the company would not continue to trade given that it is the master franchisor of the Prestige Brand and that it would be difficult to novate these contracts within the going concern period. The plausible downside scenarios show that there is no need for additional funding.

 

Based on these analyses and facts, the directors believe that the Company will be able to continue to meet its liabilities as they fall due for at least the next 12 months and therefore have prepared the financial statements on a going concern basis.

Small company

This report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

On behalf of the board
Mrs J M Renton
Director
30 May 2023
PRESTIGE NURSING (FRANCHISE) LTD
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 AUGUST 2022
- 3 -

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law they have elected to prepare the financial statements in accordance with UK accounting standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 101 Reduced Disclosure Framework. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     assess the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and

  •     use the going concern basis of accounting unless they either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error, and have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the company and to prevent and detect fraud and other irregularities.

PRESTIGE NURSING (FRANCHISE) LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF PRESTIGE NURSING (FRANCHISE) LTD
- 4 -
Opinion

We have audited the financial statements of Prestige Nursing (Franchise) Ltd (the 'company') for the year ended 31 August 2022 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 101 Reduced Disclosure Framework (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 August 2022 and of its profit for the year then ended;

  •     have been properly prepared in accordance with UK accounting standards, including FRS 101 and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities are described below. We have fulfilled our ethical responsibilities under, and are independent of the company in accordance with, UK ethical requirements including the FRC Ethical Standard. We believe that the audit evidence we have obtained is a sufficient and appropriate basis for our opinion.

Going concern

The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company’s financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements (“the going concern period”).

In our evaluation of the directors’ conclusions, we considered the inherent risks to the Company’s business model and analysed how those risks might affect the Company’s financial resources or ability to continue operations over the going concern period.

Our conclusions based on this work:

  • we consider that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate;

  • we have not identified, and concur with the directors’ assessment that there is not, a material uncertainty related to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for the going concern period.

However, as we cannot predict all future events or conditions and as subsequent events may result in outcomes that are inconsistent with judgements that were reasonable at the time they were made, the above conclusions are not a guarantee that the Company will continue in operation.

Fraud and breaches of laws and regulations – ability to detect

Identifying and responding to risks of material misstatement due to fraud

To identify risks of material misstatement due to fraud (“fraud risks”) we assessed events or conditions that could indicate an incentive or pressure to commit fraud or provide an opportunity to commit fraud. Our risk assessment procedures included:

 

  • Enquiring of directors as to the Company’s high-level policies and procedures to prevent and detect fraud, as well as whether they have knowledge of any actual, suspected or alleged fraud.

  • Reading Board minutes.

  • Using analytical procedures to identify any unusual or unexpected relationships.

PRESTIGE NURSING (FRANCHISE) LTD
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF PRESTIGE NURSING (FRANCHISE) LTD
- 5 -

We communicated identified fraud risks throughout the audit team and remained alert to any indications of fraud throughout the audit.

As required by auditing standards, and taking into account possible pressures to meet profit targets, we perform procedures to address the risk of management override of controls and the risk of fraudulent revenue recognition, in particular:

  • the risk that management may be in a position to make inappropriate accounting entries; and

  • the risk that revenue is overstated through recording revenues in the wrong period.

 

We did not identify any additional fraud risks.

 

Identifying and responding to risks of material misstatement related to compliance with laws and regulations

We identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial and sector experience and through discussion with the directors and other management (as required by auditing standards), and discussed with the directors and other management the policies and procedures regarding compliance with laws and regulations.

 

We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit.

 

The potential effect of these laws and regulations on the financial statements varies considerably.

 

Firstly, the Company is subject to laws and regulations that directly affect the financial statements including financial reporting legislation (including related companies legislation), distributable profits legislation and taxation legislation and we assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items.

 

Secondly, the Company is subject to many other laws and regulations where the consequences of non-compliance could have a material effect on amounts or disclosures in the financial statements, for instance through the imposition of fines or litigation. We identified the following areas as those most likely to have such an effect: health and safety, data protection laws, anti-bribery and employment law. Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the directors and other management and inspection of regulatory and legal correspondence, if any. Therefore if a breach of operational regulations is not disclosed to us or evident from relevant correspondence, an audit will not detect that breach.

 

Context of the ability of the audit to detect fraud or breaches of law or regulation

 

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it.

In addition, as with any audit, there remained a higher risk of non-detection of fraud, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. Our audit procedures are designed to detect material misstatement. We are not responsible for preventing non-compliance or fraud and cannot be expected to detect non-compliance with all laws and regulations.

Directors' report

The directors are responsible for the directors’ report. Our opinion on the financial statements does not cover those reports and we do not express an audit opinion thereon.

Our responsibility is to read the directors’ report and, in doing so, consider whether, based on our financial statements audit work, the information therein is materially misstated or inconsistent with the financial statements or our audit knowledge. Based solely on that work:

  • we have not identified material misstatements in the directors’ report;

  • in our opinion the information given in that report for the financial year is consistent with the financial statements; and

  • in our opinion that report has been prepared in accordance with the Companies Act 2006

PRESTIGE NURSING (FRANCHISE) LTD
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF PRESTIGE NURSING (FRANCHISE) LTD
- 6 -
Matters on which we are required to report by exception

Under the Companies Act 2006 we are required to report to you if, in our opinion

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit.

  •     the directors were not entitled to take advantage of the small companies exemption from the requirement to prepare a strategic report.

 

We have nothing to report in these respects.

Responsibilities of directors

As explained more fully in their statement set out on page 3, the directors are responsible for: the preparation of the financial statements and for being satisfied that they give a true and fair view; such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error; assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and using the going concern basis of accounting unless they either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue our opinion in an auditor’s report. Reasonable assurance is a high level of assurance, but does not guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements.

A fuller description of our responsibilities is provided on the FRC’s website at www.frc.org.uk/auditorsresponsibilities.

The purpose of our audit work and to whom we owe our responsibilities

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members, as a body, for our audit work, for this report, or for the opinions we have formed.

Andrew Reddington (Senior Statutory Auditor)
For and on behalf of KPMG LLP
30 May 2023
Chartered Accountants
Statutory Auditor
1 St. Peter's Square
Manchester
M2 3AE
PRESTIGE NURSING (FRANCHISE) LTD
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 AUGUST 2022
- 7 -
2022
2021
Notes
£
£
Revenue
3
646,395
575,611
Administrative expenses
(13,023)
(13,526)
Profit before taxation
4
633,372
562,085
Tax on profit
6
(120,483)
(106,939)
Profit and total comprehensive income for the financial year
512,889
455,146

All amounts relate to continuing operations. The notes on pages pages 10 to 17 form part of these financial statements.

PRESTIGE NURSING (FRANCHISE) LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 AUGUST 2022
31 August 2022
- 8 -
2022
2021
Notes
£
£
£
£
Current assets
Trade and other receivables
9
129,100
53,716
Cash and cash equivalents
997,663
415,700
1,126,763
469,416
Current liabilities
10
(463,541)
(319,083)
Net current assets
663,222
150,333
Equity
Called up share capital
12
2
2
Retained earnings
663,220
150,331
Total equity
663,222
150,333
The financial statements were approved by the board of directors and authorised for issue on 30 May 2023 and are signed on its behalf by:
Mrs J M Renton
Director
Company registration number 03293367
PRESTIGE NURSING (FRANCHISE) LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2022
- 9 -
Share capital
Retained earnings
Total
Notes
£
£
£
Balance at 1 September 2020
2
130,185
130,187
Year ended 31 August 2021:
Profit and total comprehensive income for the year
-
455,146
455,146
Dividends
7
-
(435,000)
(435,000)
Balance at 31 August 2021
2
150,331
150,333
Year ended 31 August 2022:
Profit and total comprehensive income for the year
-
512,889
512,889
Balance at 31 August 2022
2
663,220
663,222
PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2022
- 10 -
1
Accounting policies
Company information

Prestige Nursing (Franchise) Ltd is a private company limited by shares incorporated and domiciled in England and Wales. The registered number is 03293367 and the registered office is 1st Floor, Kirkgate, 19-31 Church Street, Epsom, Surrey, KT17 4PF. The company's principal activities and nature of its operations are disclosed in the directors' report.

1.1
Accounting convention

The financial statements have been prepared in accordance with Financial Reporting Standard 101 Reduced Disclosure Framework (FRS 101) and in accordance with applicable accounting standards.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below and have been applied consistently to all periods presented in the financial statements, unless otherwise stated.

The company has taken advantage of the following disclosure exemptions under FRS 101:

  • the requirements of paragraphs 45(b) and 46-52 of IFRS 2 Share based Payment;

  • the requirements of paragraphs 62, B64(d), B64(e), B64(g), B64(h), B64(j) to B64(m), B64(n)(ii), B64 (o)(ii), B64(p), B64(q)(ii), B66 and B67of IFRS 3 Business Combinations. Equivalent disclosures are included in the consolidated financial statements of Sodexo S.A in which the entity is consolidated;

  • the requirements of paragraph 33 (c) of IFRS 5 Non current Assets Held for Sale and Discontinued Operations;

  • the requirements of IFRS 7 Financial Instruments: Disclosures;

  • the requirements of paragraphs 91-99 of IFRS 13 Fair Value Measurement;

  • the requirement in paragraph 38 of IAS 1 ‘Presentation of Financial Statements’ to present comparative information in respect of: (i) paragraph 79(a) (iv) of IAS 1, (ii) paragraph 73(e) of IAS 16 Property Plant and Equipment (iii) paragraph 118 (e) of IAS 38 Intangibles Assets, (iv) paragraphs 76 and 79(d) of IAS 40 Investment Property and (v) paragraph 50 of IAS 41 Agriculture;

  • the requirements of paragraphs 10(d), 10(f), 16, 38A to 38D, 39 to 40 ,111 and 134-136 of IAS 1 Presentation of Financial Statements;

  • the requirements of IAS 7 Statement of Cash Flows;

  • the requirements of paragraphs 30 and 31 of IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors;

  • the requirements of paragraph 17 of IAS 24 Related Party Disclosures;

  • the requirements in IAS 24 Related Party Disclosures to disclose related party transactions entered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member ; and

  • the requirements of paragraphs 134(d)-134(f) and 135(c)-135(e) of IAS 36 Impairment of Assets.

 

As permitted by FRS 101, the company has taken advantage of the disclosure exemptions available under that standard in relation to share based payments, financial instruments, capital management, presentation of a cash flow statement, presentation of comparative information in respect of certain assets, standards not yet effective, impairment of assets, business combinations, discontinued operations and related party transactions.

The Company’s ultimate parent undertaking, Sodexo S.A. includes the Company in its consolidated financial statements. The consolidated financial statements of Sodexo S.A. are prepared in accordance with International Financial Reporting Standards and are available to the public and are published on the company's website at www.sodexo.com.

Judgements made by the directors, in the application of these accounting policies that have significant effect on the financial statements and estimates with a significant risk of material adjustment in the next year are discussed in note 2.

PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
1
Accounting policies
(Continued)
- 11 -
1.2
Going concern

The directors continue to adopt the going concern basis in the preparation of the financial statements. true

 

The business has remained resilient through the UK wide Covid-19 lockdowns which ended on 18 July 2021 due to the essential nature of the service its franchisees provide and the high proportion of local government and health service clients. We continue to see opportunities for organic growth provided that we can continue to attract, recruit and retain professional carer in an increasingly tight labour market.

 

As inflationary pressures increase, we continue to work with our franchisees and their clients to ensure they receive a fair price for the services that they provide, so that they can continue to invest in their workforce. Agility, good commercial management, and careful cost control continue to be critical to our mutual ongoing success.

 

To inform the basis of preparation of these accounts, the directors have considered cash and profit scenarios for forward trade over the next 12 months.

 

Routine peaks in cash requirements during the trading cycle, can be funded from the significant cash balance the company / its immediate parent company (Prestige Nursing Ltd) has on hand at the end of the 2022 financial year.

 

As at the date of approval of the financial statements, the shareholders of Prestige Nursing Ltd are exploring various strategic options with regard to their shareholding, including the sale of their shares. Although the outcome of the process is currently uncertain, the directors have considered the consequences if a sale was to occur in the forecast period. It is not possible to predict what would happen to the entity if there was a sale, however, the directors have no reason to believe that the company would not continue to trade given that it is the master franchisor of the Prestige Brand and that it would be difficult to novate these contracts within the going concern period. The plausible downside scenarios show that there is no need for additional funding.

 

Based on these analyses and facts, the directors believe that the Company will be able to continue to meet its liabilities as they fall due for at least the next 12 months and therefore have prepared the financial statements on a going concern basis.

1.3
Revenue

Franchise fees are calculated based on the underlying gross profit earned by each franchisee as specified in the relevant franchise agreement. The fees are based on an agreed percentage of each franchisee's gross profits.

1.4
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office equipment
Over 3 years on a straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the income statement.

PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
1
Accounting policies
(Continued)
- 12 -
1.5
Fair value measurement

IFRS 13 establishes a single source of guidance for all fair value measurements. IFRS 13 does not change when an entity is required to use fair value, but rather provides guidance on how to measure fair value under IFRS when fair value is required or permitted. The company is exempt under FRS 101 from the disclosure requirements of IFRS 13. There was no impact on the company from the adoption of IFRS 13.

1.6
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial assets

Financial assets are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument. Financial assets are classified into specified categories, depending on the nature and purpose of the financial assets.

 

At initial recognition, financial assets classified as fair value through profit and loss are measured at fair value and any transaction costs are recognised in profit or loss. Financial assets not classified as fair value through profit and loss are initially measured at fair value plus transaction costs.

Financial assets held at amortised cost

Trade Receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as loans and receivables. Loans and receivables are measured at amortised cost using the effective interest method, less any impairment.

 

Interest is recognised by applying the effective interest rate, except for short-term receivables when the recognition of interest would be immaterial. The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating the interest income over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the debt instrument to the net carrying amount on initial recognition.

Impairment of financial assets

Financial assets carried at amortised cost and fair value through other comprehensive income are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that

occurred after the initial recognition of the financial asset, the estimated future cash flows of the investment

have been affected.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership to another entity.

1.8
Financial liabilities

The company recognises financial debt when the company becomes a party to the contractual provisions of the instruments. Financial liabilities are classified as either 'financial liabilities at fair value through profit or loss' or 'other financial liabilities'.

Other financial liabilities

Other financial liabilities, including borrowings, trade payables and other short-term monetary liabilities, are initially measured at fair value net of transaction costs directly attributable to the issuance of the financial liability. They are subsequently measured at amortised cost using the effective interest method. For the purposes of each financial liability, interest expense includes initial transaction costs and any premium payable on redemption, as well as any interest or coupon payable while the liability is outstanding.

PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
1
Accounting policies
(Continued)
- 13 -
Derecognition of financial liabilities

Financial liabilities are derecognised when, and only when, the company’s obligations are discharged, cancelled, or they expire.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets and liabilities are not recognised if the temporary difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
- 14 -
2
Critical accounting estimates and judgements

The preparation of financial statements requires the management to make estimates and judgements which affect the amounts reported for assets, liabilities and contingent liabilities as of the date of preparation of the financial statements, and for revenues and expenses for the period.

 

Estimates and underlying assumptions are continually evaluated and are based on historical experience and other factors, including expectations of future events that are reasonable under the circumstances. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected.

 

The estimates and judgements that have the most material impact on the financial performance and position of the Company are as follows:

 

(i) Provisions for bad debts

Provision is made for aged debts. These provisions require management’s best estimate of the likelihood of recovery of each debt.

3
Revenue
2022
2021
£
£
Revenue analysed by class of business
Franchise fees
646,395
575,611
2022
2021
£
£
Revenue analysed by geographical market
UK Market
646,395
575,611
4
Operating profit
2022
2021
Operating profit for the year is stated after charging/(crediting):
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
2,718
3,370
5
Employees

The directors received no remuneration from Prestige Nursing (Franchise) Ltd during the year. Directors receive remuneration from another of the Sodexo group companies. The average monthly number of persons employed by the company during the year was:

2022
2021
Number
Number
Total
-
0
-
0
PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
- 15 -
6
Income tax expense
2022
2021
£
£
Current tax
UK corporation tax on profits for the current period
120,483
106,939

The charge for the year can be reconciled to the profit per the income statement as follows:

2022
2021
£
£
Profit before taxation
633,372
562,085
Expected tax charge based on a corporation tax rate of 19.00% (2021: 19.00%)
120,341
106,796
Effect of expenses not deductible in determining taxable profit
142
143
Taxation charge for the year
120,483
106,939

On 1 April 2017, the standard rate of corporation tax changed to 19%. For the purpose of the company accounts to 31 August 2022, the standard rate of corporation tax has been applied.

 

The March 2020 Budget announced that a rate of 19% would continue to apply with effect from 1 April 2020, and this change was substantively enacted on 17 March 2020. In the 3 March 2021 Budget it was announced that the UK tax rate will increase to 25% from 1 April 2023 for companies with profits over £250,000. This will have a consequential effect on the company’s future tax charge.

7
Dividends
2022
2021
2022
2021
Amounts recognised as distributions:
per share
per share
Total
Total
£
£
£
£
Ordinary
Interim dividend paid
-
217,500
-
435,000
PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
- 16 -
8
Property, plant and equipment
Office equipment
£
Cost
At 1 September 2021
4,669
Disposals
(4,669)
At 31 August 2022
-
0
Accumulated depreciation and impairment
At 1 September 2021
4,669
Eliminated on disposal
(4,669)
At 31 August 2022
-
0
Carrying amount
At 31 August 2022
-
0
At 31 August 2021
-
0
9
Trade and other receivables
2022
2021
£
£
Trade receivables
127,872
-
Other receivables
-
52,592
Prepayments and accrued income
1,228
1,124
129,100
53,716

Trade receivables disclosed above are classified as receivables and are therefore measured at amortised cost.

10
Liabilities
2022
2021
Notes
£
£
Trade and other payables
11
439,247
108,996
Corporation tax
78
200,607
Other taxation and social security
24,216
9,480
463,541
319,083
PRESTIGE NURSING (FRANCHISE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2022
- 17 -
11
Trade and other payables
2022
2021
£
£
Amount owed to parent undertaking
435,167
104,916
Accruals and deferred income
4,080
4,080
439,247
108,996
12
Share capital
2022
2021
£
£
Ordinary share capital
Issued and fully paid
2 Ordinary of £1 each
2
2
2
2
13
Capital commitments

There were no capital commitments in place as at 31 August 2022 (2021: £nil).

14
Controlling party

The parent company of Prestige Nursing (Franchise) Ltd is Prestige Nursing Ltd and its registered office is 1st Floor, Kirkgate, 19-31 Church Street, Epsom, Surrey, KT17 4PF.

 

The ultimate controlling party (and the group into which the entity is consolidated) is Sodexo SA. Its registered office is 255 quai de la Bataille de Stalingrad, 92130 Issy les Mounlineaux, France.

 

2022-08-312021-09-01Mr S MistryMr D J B SandozMrs J M RentonMrs V SapojnicSodexo Corporate Services (No.2) LimitedfalseCCH SoftwareiXBRL Review & Tag 2022.2032933672021-09-012022-08-3103293367bus:Director12021-09-012022-08-3103293367bus:Director22021-09-012022-08-3103293367bus:Director32021-09-012022-08-3103293367bus:Director42021-09-012022-08-3103293367bus:CompanySecretary12021-09-012022-08-3103293367bus:RegisteredOffice2021-09-012022-08-31032933672022-08-31032933672020-09-012021-08-3103293367core:ContinuingOperations2021-09-012022-08-3103293367core:RetainedEarningsAccumulatedLosses2021-09-012022-08-3103293367core:RetainedEarningsAccumulatedLosses2020-09-012021-08-31032933672021-08-3103293367core:ShareCapital2022-08-3103293367core:ShareCapital2021-08-3103293367core:RetainedEarningsAccumulatedLosses2022-08-3103293367core:RetainedEarningsAccumulatedLosses2021-08-31032933672020-08-3103293367core:ShareCapitalOrdinaryShares2022-08-3103293367core:ShareCapitalOrdinaryShares2021-08-3103293367core:LoansReceivables2021-09-012022-08-3103293367core:ComputerEquipment2021-08-3103293367core:ComputerEquipment2022-08-3103293367core:ComputerEquipment2021-09-012022-08-3103293367core:ComputerEquipment2021-08-3103293367core:CurrentFinancialInstruments2022-08-3103293367core:CurrentFinancialInstruments2021-08-3103293367core:WithinOneYear2022-08-3103293367core:WithinOneYear2021-08-3103293367bus:OrdinaryShareClass12021-09-012022-08-3103293367bus:PrivateLimitedCompanyLtd2021-09-012022-08-3103293367bus:Audited2021-09-012022-08-3103293367bus:FRS1012021-09-012022-08-3103293367bus:FullAccounts2021-09-012022-08-31xbrli:purexbrli:sharesiso4217:GBP